Retatrutide 40mg Synedica

The Synedica Retatrutide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.

Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.

Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.

 Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

 Suitable R&D Applications

 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

 Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications